+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application (Diagnostics (Clinical, PoC), Research (Proteomic, Genomics, Cell), Therapeutics (Drug Delivery, Wearables)), End User- Global Forecast to 2029

  • PDF Icon

    Report

  • 361 Pages
  • October 2024
  • Region: Global
  • Markets and Markets
  • ID: 5449009

The Microfluidics market is projected to reach USD 32.67 Billion by 2029 from USD 22.43 Billion in 2024, growing at a CAGR of 7.8% during the forecast period. The market for microfluidics is expanding due to a number of important factors. The growing requirement for point-of-care diagnostics is one of an important factor. The necessity for fast and accurate diagnosis has risen due to the increase in chronic diseases like cancer and diabetes, which is propelling the application of microfluidics in healthcare. Furthermore, the use of microfluidic devices is increasing due to innovations in drug delivery, organ-on-a-chip technology, and personalized medicine. Additionally, the market is driven by the rise in proteomics and genomics associated research.

Polymers to account for largest market share in 2023

The market for microfluidics is propelled by polymers because of their their low costs, ease of production and adaptability. Microfluidic device manufacturing often requires polymers such as polydimethylsiloxane (PDMS), polymethyl methacrylate (PMMA), and cyclic olefin copolymer (COC). These polymers are helpful in the fabrication of microfluidic channels and structures. Moreover, as compared to conventional materials like silicon or glass, polymers are easier to mold and also, enables cheaper manufacturing costs. The biocompatible property of polymers makes them useful for a variety of medical applications, including medication delivery, lab-on-a-chip, and diagnostics. Due to such advantages, polymers accounts for the largest share in the microfluidics market.

Hospital and Diagnostic Centers to register highest growth rate in the market during the forecast period

Various significant factors are propelling the growth of hospitals and diagnostic centers in the microfluidics industry. One important factor is the rising requirement for point-of-care diagnostics, as they provides quick, on-site testing that improves patient outcomes. Microfluidics play a major role in this positive outcome as it offers faster and precise result . Moreover, the requirement for efficacious diagnostics in clinical settings has risen due to the increase in infectious diseases like COVID-19. These equipment decreases cost, expedites testing methods, and improve precision and accuracy of diagnosis.

Asia Pacific to register highest growth rate in the market during the forecast period

The highest CAGR was registered by the APAC region throughout the forecast period from 2024-2029. Asia Pacific comprise India, China, Japan, Australia, South Korea and RoAPAC. The demand for innovative technologies is increasing, especially in China, India, and Japan. Microfluidic devices for diagnostic and therapeutic applications are used due to the rise in prevalence of chronic and infectious diseases and the increase in focus on early diagnosis and preventative healthcare. The region's rising pharmaceutical and lifesciences industries are also undertaking research and development initiatives, which increases the requirement for microfluidics in personalized medicine and drug discovery.

Abreakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1 - 30%, Tier 2 - 42%, and Tier 3 - 28%
  • By Designation: C-level- - 14%, Director-level - 10%, and Others - 76%
  • By Region: North America - 40%, Europe - 30%, Asia Pacific - 22%, Rest of the World - 8%.

Prominent players in this market are Abbott laboratories (US), Agilent Technologies, Inc. (US), Aignep S.P.A (Italy), biomerieux (France), BD(US), Bio-Rad laboratories, Inc (US), Danaher Corporation (US), Illumina Inc. (US), Parker Hannifin Coporation (US), Thermo Fisher Scientific Inc. (US), SMC Corporation (Japan), Idex Corporation (US), Fortive Corporation (US), Perkinelmer, Inc. (US), F.Hoffmann-LA Roche Ltd (Switzerland), Standard Biotools Inc. (US), Quidelortho Corporation (US), Hologic Inc. (US), Dolomite Microfluidics (UK) and Elveflow (France).

Research Coverage

The report comprise segmentation that covers end users, products, applications, and geographic regions. It also covers the key drivers, restraints, opportunities, and challenges impacting the growth trajectory of the microfluidics market. The research offers stakeholders an in-depth analysis of market potential and challenges, with a focus on major players and competitive landscapes. Moreover, micromarkets are analysed as per their overall impact to the global microfluidics sector, growth patterns, and potential. The analysis forecasts rise in market segment revenues, focusing on five key regions.

Key Benefits of Buying the Report

The purpose of this research is to assist both new and existing players in the microfluidics market to assess the sustainability of their investments by providing detailed and knowledgeable information. It offers a dataset to assist in making key decisions. This report's potential to facilitate thorough risk evaluation and provide direction for investment decisions is one of its major benefit. Market segmentation according to end-users and geographical areas is provided in the study, that provides precise analysis and insights. It also provide significant trends, obstacles, opportunities, and drivers, giving stakeholders the information they require to make strategic decisions that help in their long-term growth.

The report provides the insights on the following pointers:

Analysis of the key drivers, restraints, opportunities, and challenges affecting the microfluidics market growth: Innovative technology and increase in prevalence of chronic diseases ; increased cost of devices and stringent regulations ; increase in number of diagnostic centers.

  • Product Development/Innovation: Overview of technologies, research & development ventures and launch of innovative product & service for the microfluidics industry.
  • Market Development: Details associated with profitable markets: this research studies the microfluidics business in various geographical regions.
  • Market Diversification: In-depth understanding of innovative products, unexamined regions, recent developments, and expenditures in the microfluidics market.
  • Competitive Assessment: Detailed analysis of market share, services and products offered and key strategies adopted by prominent players such as Danaher Corporation (US), Illumina Inc. (US), biomerieux (France), Thermo Fisher Scientific Inc. (US) and Abbott laboratories (US).

Table of Contents

1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Market Stakeholders
1.5 Summary of Changes
2 Research Methodology
2.1 Research Data
2.2 Research Design
2.2.1 Secondary Research
2.2.1.1 Key Data from Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Industry Insights
2.3 Market Size Estimation Methodology
2.3.1 Bottom-Up Approach
2.3.1.1 Approach 1: Company Revenue Estimation Approach
2.3.1.2 Approach 2: Customer-based Market Estimation
2.3.1.3 Approach 3: Top-Down Approach
2.3.1.4 Approach 4: Primary Interviews
2.3.1.5 Growth Forecast
2.3.1.6 CAGR Projection
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Market Share Assessment
2.6 Research Assumptions
2.7 Research Limitations
2.8 Risk Assessment
3 Executive Summary
4 Premium Insights
4.1 Microfluidics Market Overview
4.2 Asia-Pacific: Microfluidics Market, by End-user and Country (2023)
4.3 Microfluidics Market, by Region
4.4 Geographic Snapshot of Microfluidics Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Requirement for Point-Of-Care Testing
5.2.1.2 Rising Technological Advancements
5.2.1.3 Increasing Focus on Data Precision and Accuracy
5.2.1.4 Economic Benefits Associated with Microfluidics
5.2.1.5 Portability with Microfluidic Chip Miniaturization
5.2.1.6 Rising Demand for Effective Sample Analysis
5.2.2 Restraints
5.2.2.1 Stringent Regulatory Approval Process
5.2.2.2 Integration of Microfluidics into Current Workflow
5.2.3 Opportunities
5.2.3.1 Emergence of 3D Cell Culture Systems
5.2.3.2 Growth Potential of Emerging Economies
5.2.3.3 Use of Microfluidics in Life Sciences & Pharmaceutical Industries
5.2.4 Challenges
5.2.4.1 Low Adoption of Microfluidic Devices Among End-users
5.3 Industry Trends
5.3.1 E-Health Diagnostics
5.3.2 Integration of Microfluidics with 3D Printing
5.3.3 R&D Investments for Product Development
5.4 Porter's Five Forces Analysis
5.4.1 Threat of New Entrants
5.4.2 Threat of Substitutes
5.4.3 Bargaining Power of Suppliers
5.4.4 Bargaining Power of Buyers
5.4.5 Intensity of Competitive Rivalry
5.5 Key Stakeholders & Buying Criteria
5.5.1 Key Stakeholders in Buying Process
5.5.2 Buying Criteria
5.6 Regulatory Landscape
5.6.1 North America
5.6.1.1 US
5.6.1.2 Canada
5.6.2 Europe
5.6.3 Asia-Pacific
5.6.3.1 Japan
5.6.3.2 China
5.6.3.3 India
5.6.4 Regulatory Bodies, Government Agencies, and Other Organizations
5.7 Reimbursement Scenario
5.8 Ecosystem Analysis
5.9 Value Chain Analysis
5.9.1 Research & Development
5.9.2 Raw Material Procurement & Manufacturing
5.9.3 Marketing & Sales, Distribution, and Post-Sales Services
5.10 Supply Chain Analysis
5.11 Trends/Disruptions Impacting Customers’ Businesses
5.12 Impact of Gen AI on Microfluidics Market
5.13 Patent Analysis
5.13.1 Patent Publication Trends for Microfluidics
5.13.2 Insights: Jurisdiction and Top Applicant Analysis
5.14 Trade Analysis
5.14.1 Import Data
5.14.2 Export Data
5.15 Technology Analysis
5.15.1 Key Technologies
5.15.1.1 Biosensor Elements
5.15.1.2 Materials Science
5.15.1.3 Microfabrication
5.15.1.4 Direct-Writing
5.15.2 Complementary Technologies
5.15.2.1 Mems
5.15.2.1.1 Green Microfluidics
5.15.2.1.2 Microsensors/Transducers
5.15.3 Adjacent Technologies
5.15.3.1 3D Inkjet Printing
5.15.3.2 Lab-On-Fiber
5.16 Key Conferences & Events
5.17 Pricing Analysis
5.17.1 Average Selling Price Trend, by Region
5.17.2 Average Selling Price Trend of Top 3 Applications, by Key Player
5.18 Unmet Needs/End-user Expectations in Microfluidics Market
5.19 Case Study Analysis
5.19.1 Case Study 1: Multiplex Microfluidic Circuit for Blood Vessel-On-A-Chip Perfusion Using Flowez
5.19.2 Case Study 2: Microfluidic System for Robotic Hand Playing Nintendo
5.19.3 Case Study 3: 3D-Printed Microfluidic Devices Using Polyjet Technology
5.20 Investment & Funding Scenario
6 Microfluidics Market, by Product
6.1 Introduction
6.2 Microfluidics-based Devices
6.2.1 High Uptake of Poc Testing and Organ-On-A-Chip Systems To Propel Market
6.3 Microfluidic Components
6.3.1 Microfluidic Components, by Type
6.3.1.1 Microfluidic Chips
6.3.1.1.1 Chips to Account for Largest Share of Components Market
6.3.1.2 Flow & Pressure Sensors
6.3.1.2.1 Utilization in Lab Diagnostics & Research Applications to Drive Market
6.3.1.3 Flow & Pressure Controllers
6.3.1.3.1 Cost-Effectiveness and Durability to Boost Demand
6.3.1.4 Microfluidic Valves
6.3.1.4.1 Technological Advancements to Support Market Growth
6.3.1.5 Micropumps
6.3.1.5.1 Wide Usage in Drug Delivery and Glucose Injections to Fuel Uptake
6.3.1.6 Microneedles
6.3.1.6.1 Miniscule Size and Painless Patch Application Procedure to Boost Demand
6.3.1.7 Other Microfluidic Components
6.3.2 Microfluidic Components, by Material
6.3.2.1 Silicon
6.3.2.1.1 High Precision and Durability to Boost Demand
6.3.2.2 Polymers
6.3.2.2.1 Polymethyl Methacrylate (Pmma)
6.3.2.2.1.1 Durable Alternative to Glass to Fuel Uptake
6.3.2.2.2 Polydimethylsiloxane (Pdms)
6.3.2.2.2.1 Limited Compatibility with Specific Solvents and Acids to Limit Market Adoption
6.3.2.2.3 Cyclic Olefin Copolymers
6.3.2.2.3.1 Low Water Absorption and Enhanced Electrical Insulation Properties to Boost Demand
6.3.2.2.4 Other Polymers
6.3.2.3 Glass
6.3.2.3.1 High Cost and Brittleness to Restrain Market
7 Microfluidics Market, by Application
7.1 Introduction
7.2 Ivd
7.2.1 Clinical Diagnostics
7.2.1.1 Growing Focus on Early Disease Detection to Drive Market
7.2.2 Point-Of-Care Testing (Poct)
7.2.2.1 High Uptake of Lab-On-A-Chip Technologies to Fuel Uptake
7.2.3 Veterinary Diagnostics
7.2.3.1 Detection of Toxins in Food Through Loc Systems to Support Market Growth
7.3 Pharmaceutical & Life Science Research
7.3.1 Lab Analytics
7.3.1.1 Proteomic Analysis
7.3.1.1.1 Utilization of Lab-On-A-Chip Devices for Therapeutic Development to Drive Market
7.3.1.2 Genomic Analysis
7.3.1.2.1 Growing Focus on Ngs and Digital Pcr to Boost Demand
7.3.1.3 Cell-based Assays
7.3.1.3.1 Drug-Screening for Cross-Reaction & Toxicity Testing to Support Market Growth
7.3.1.4 Capillary Electrophoresis
7.3.1.4.1 Growing Applications for Environmental Monitoring and Clinical Diagnostics to Fuel Uptake
7.3.2 Microdispensing
7.3.2.1 Suitability for Low-Viscosity Applications to Support Market Growth
7.3.3 Microreactors
7.3.3.1 High Uptake by Leading Companies for Process Optimization to Fuel Market
7.4 Therapeutics
7.4.1 Drug Delivery
7.4.1.1 Utilization of Microneedles for Painless and Precise Delivery to Drive Market
7.4.2 Wearable Devices
7.4.2.1 Integration of Microfluidics-based Wearable Devices to Support Market Growth
8 Microfluidics Market, by End-user
8.1 Introduction
8.2 Hospitals and Diagnostic Centers
8.2.1 Availability of Technologically Advanced Equipment and Focus on Early Disease Diagnosis to Boost Demand
8.3 Academic & Research Institutes
8.3.1 Investments in Biomedical & Life Science Research to Support Market Growth
8.4 Pharmaceutical & Biotechnology Companies
8.4.1 Growing Focus on Biomarker & Drug Discovery to Propel Market
9 Microfluidics Market, by Region
9.1 Introduction
9.2 North America
9.2.1 Macroeconomic Outlook for North America
9.2.2 US
9.2.2.1 High Healthcare Expenditure and Wide Adoption of Technologically Advanced Products to Drive Market
9.2.3 Canada
9.2.3.1 Government Funds and Focus on Research to Support Market Growth
9.3 Europe
9.3.1 Macroeconomic Outlook for Europe
9.3.2 Germany
9.3.2.1 Growing Focus on Proteomics & Genomics Research to Drive Market
9.3.3 France
9.3.3.1 Favorable Government Support for R&D to Drive Market
9.3.4 UK
9.3.4.1 Rising Cases of Chronic Diseases and Increasing Demand for Poc Testing to Boost Demand
9.3.5 Italy
9.3.5.1 Innovative Development of Microfluidic Chips to Boost Demand
9.3.6 Spain
9.3.6.1 Growth in Pharmaceutical Industry to Fuel Uptake
9.3.7 Rest of Europe
9.4 Asia-Pacific
9.4.1 Macroeconomic Outlook for Asia-Pacific
9.4.2 China
9.4.2.1 Growing Focus on Nanotechnology to Drive Market
9.4.3 Japan
9.4.3.1 High Investments in Academic Research Activities to Propel Market
9.4.4 India
9.4.4.1 Increasing Prevalence of Cvd and Diabetes to Support Market Growth
9.4.5 Australia
9.4.5.1 Rising Incidence of Infectious Diseases to Fuel Uptake
9.4.6 South Korea
9.4.6.1 Increasing R&D Expenditure to Drive Growth
9.4.7 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Macroeconomic Outlook for Latin America
9.5.2 Brazil
9.5.2.1 Increasing Development of Disease Diagnostics Kits to Fuel Uptake
9.5.3 Mexico
9.5.3.1 Rising Prevalence of Chronic Diseases to Boost Demand for Poc Testing
9.5.4 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Macroeconomic Outlook for Middle East & Africa
9.6.2 GCC Countries
9.6.2.1 Adoption of Advanced Microfluidic Devices to Support Market Growth
9.6.3 Rest of Middle East & Africa
10 Competitive Landscape
10.1 Introduction
10.2 Key Player Strategy/Right to Win
10.3 Overview of Strategies Adopted by Key Players in Microfluidics Market
10.4 Revenue Analysis
10.5 Market Share Analysis by Key Players, 2023
10.6 Ranking of Key Market Players
10.7 Company Evaluation Matrix: Key Players, 2023
10.7.1 Stars
10.7.2 Emerging Leaders
10.7.3 Pervasive Players
10.7.4 Participants
10.7.5 Company Footprint: Key Players, 2023
10.7.5.1 Company Footprint
10.7.5.2 Product Footprint
10.7.5.3 Application Footprint
10.7.5.4 End-user Footprint
10.7.5.5 Region Footprint
10.8 Company Evaluation Matrix: Startups/SMEs, 2023
10.8.1 Progressive Companies
10.8.2 Responsive Companies
10.8.3 Dynamic Companies
10.8.4 Starting Blocks
10.8.5 Competitive Benchmarking: Startups/SMEs, 2023
10.8.5.1 Detailed List of Key Startup/SME Players
10.8.5.2 Competitive Benchmarking of Key Emerging Players/Startups
10.9 Company Valuation & Financial Metrics
10.9.1 Financial Metrics
10.9.2 Company Valuation
10.10 Brand/Product Comparative Analysis
10.11 Competitive Scenario
10.11.1 Product Launches & Approvals
10.11.2 Deals
10.11.3 Expansions
10.11.4 Other Developments
11 Company Profiles
11.1 Key Players
11.1.1 Danaher Corporation
11.1.1.1 Business Overview
11.1.1.2 Products Offered
11.1.1.3 Recent Developments
11.1.1.3.1 Deals
11.1.1.3.2 Expansions
11.1.1.4 Analyst's View
11.1.1.4.1 Key Strengths
11.1.1.4.2 Strategic Choices
11.1.1.4.3 Weaknesses & Competitive Threats
11.1.2 Illumina, Inc.
11.1.2.1 Business Overview
11.1.2.2 Products Offered
11.1.2.3 Recent Developments
11.1.2.3.1 Product Launches & Approvals
11.1.2.3.2 Deals
11.1.2.4 Analyst's View
11.1.2.4.1 Key Strengths
11.1.2.4.2 Strategic Choices
11.1.2.4.3 Weaknesses & Competitive Threats
11.1.3 bioMérieux
11.1.3.1 Business Overview
11.1.3.2 Products Offered
11.1.3.3 Recent Developments
11.1.3.3.1 Product Launches & Approvals
11.1.3.4 Analyst's View
11.1.3.4.1 Key Strengths
11.1.3.4.2 Strategic Choices
11.1.3.4.3 Weaknesses & Competitive Threats
11.1.4 Thermo Fisher Scientific Inc.
11.1.4.1 Business Overview
11.1.4.2 Products Offered
11.1.4.3 Recent Developments
11.1.4.3.1 Product Launches & Approvals
11.1.4.3.2 Deals
11.1.4.3.3 Expansions
11.1.4.4 Analyst's View
11.1.4.4.1 Key Strengths
11.1.4.4.2 Strategic Choices
11.1.4.4.3 Weaknesses & Competitive Threats
11.1.5 Abbott Laboratories
11.1.5.1 Business Overview
11.1.5.2 Products Offered
11.1.5.3 Analyst's View
11.1.5.3.1 Key Strengths
11.1.5.3.2 Strategic Choices
11.1.5.3.3 Weaknesses & Competitive Threats
11.1.6 Parker Hannifin Corp
11.1.6.1 Business Overview
11.1.6.2 Products Offered
11.1.7 Smc Corporation
11.1.7.1 Business Overview
11.1.7.2 Products Offered
11.1.7.3 Recent Developments
11.1.7.3.1 Product Launches
11.1.8 Idex Corporation
11.1.8.1 Business Overview
11.1.8.2 Products Offered
11.1.8.3 Recent Developments
11.1.8.3.1 Deals
11.1.9 Fortive
11.1.9.1 Business Overview
11.1.9.2 Products Offered
11.1.10 Perkinelmer Inc.
11.1.10.1 Business Overview
11.1.10.2 Products Offered
11.1.10.3 Recent Developments
11.1.10.3.1 Product Launches
11.1.10.3.2 Deals
11.1.11 Agilent Technologies, Inc.
11.1.11.1 Business Overview
11.1.11.2 Products Offered
11.1.11.3 Recent Developments
11.1.11.3.1 Product Launches
11.1.11.3.2 Deals
11.1.11.3.3 Expansions
11.1.12 Bio-Rad Laboratories, Inc.
11.1.12.1 Business Overview
11.1.12.2 Products Offered
11.1.12.3 Recent Developments
11.1.12.3.1 Product Launches
11.1.12.3.2 Deals
11.1.13 Becton, Dickinson and Company
11.1.13.1 Business Overview
11.1.13.2 Products Offered
11.1.13.3 Recent Developments
11.1.13.3.1 Product Launches & Approvals
11.1.13.3.2 Deals
11.1.13.3.3 Expansions
11.1.14 F. Hoffmann-La Roche Ltd.
11.1.14.1 Business Overview
11.1.14.2 Products Offered
11.1.14.3 Recent Developments
11.1.14.3.1 Product Launches & Approvals
11.1.14.3.2 Deals
11.1.15 Standard Biotools
11.1.15.1 Business Overview
11.1.15.2 Products Offered
11.1.15.3 Recent Developments
11.1.15.3.1 Product Launches & Approvals
11.1.15.3.2 Deals
11.1.16 Quidelortho Corporation
11.1.16.1 Business Overview
11.1.16.2 Products Offered
11.1.16.3 Recent Developments
11.1.16.3.1 Product Approvals
11.1.16.3.2 Deals
11.1.16.3.3 Expansions
11.1.17 Hologic, Inc.
11.1.17.1 Business Overview
11.1.17.2 Products Offered
11.1.17.3 Recent Developments
11.1.17.3.1 Product Approvals
11.1.17.3.2 Deals
11.1.18 Aignep S.P.A.
11.1.18.1 Business Overview
11.1.18.2 Products Offered
11.1.18.3 Recent Developments
11.1.18.3.1 Deals
11.1.19 Dolomite Microfluidics
11.1.19.1 Business Overview
11.1.19.2 Products Offered
11.1.19.3 Recent Developments
11.1.19.3.1 Product Launches & Approvals
11.1.19.3.2 Deals
11.1.19.3.3 Other Developments
11.1.20 Elveflow
11.1.20.1 Business Overview
11.1.20.2 Products Offered
11.2 Other Players
11.2.1 Nanostring Technologies
11.2.2 Nortis Inc.
11.2.3 Innovative Biochips, LLC
11.2.4 Fluidic Analytics
11.2.5 Ufluidix
11.2.6 Horiba
11.2.7 Micronit B.V.
12 Appendix
12.1 Discussion Guide
12.2 Knowledgestore: The Subscription Portal
12.3 Customization Options
List of Tables
Table 1 Microfluidics Market: Inclusions & Exclusions
Table 2 Microfluidics Market: Study Assumptions
Table 3 Risk Assessment: Microfluidics Market
Table 4 Product Launches by Key Players, 2023
Table 5 List of University Startups in Microfluidics Market
Table 6 Microfluidics Market: Porter's Five Forces
Table 7 Influence of Stakeholders on Buying Process For Microfluidics Market
Table 8 Key Buying Criteria for Microfluidics Market, by Material
Table 9 US: Classification of Microfluidics Technology-Associated Diagnostic Devices
Table 10 Canada: Time, Cost, and Complexity of Registration
Table 11 Europe: Classification of Microfluidics Associated with Ivd Devices
Table 12 Japan: Time, Cost, and Complexity of Registration
Table 13 China: Time, Cost, and Complexity of Registration
Table 14 North America: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 15 Europe: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 16 Asia-Pacific: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 17 Latin America: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 18 Rest of the World: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 19 Major Cpt Codes for Diagnostics Tests in US, 2023
Table 20 Microfluidics Market: Role in Ecosystem
Table 21 Applications of Artificial Intelligence-Powered Microfluidics
Table 22 List of Major Patent Innovations and Patent Registrations, 2022-2024
Table 23 Import Data for HS Code 3822, by Country, 2019-2023 (USD Thousand)
Table 24 Export Data for HS Code 3822, by Country, 2019-2023 (USD Thousand)
Table 25 Microfluidics Market: Key Conferences & Events (2023-2024)
Table 26 Average Selling Price of Microfluidics Medicine Equipment, by Region, 2023 (USD Thousand)
Table 27 Average Selling Price of Top 3 Applications, by Key Player, 2023 (USD)
Table 28 Microfluidics Market: Current Unmet Needs
Table 29 Case Study 1: Multiplex Microfluidic Circuit for Blood Vessel-On-A-Chip Perfusion Using Flowez
Table 30 Case Study 2: Microfluidic System for Robotic Hand Playing Nintendo
Table 31 Case Study 3: 3D-Printed Microfluidic Devices Using Polyjet Technology
Table 32 Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 33 Microfluidics-based Devices Market, by Region, 2022-2029 (USD Million)
Table 34 Microfluidic Components Market, by Region, 2022-2029 (USD Million)
Table 35 Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 36 Microfluidic Chips Offered by Key Players
Table 37 Microfluidic Chips Market, by Region, 2022-2029 (USD Million)
Table 38 Flow & Pressure Sensors Offered by Key Players
Table 39 Flow & Pressure Sensors Market, by Region, 2022-2029 (USD Million)
Table 40 Flow & Pressure Controllers Offered by Key Players
Table 41 Flow & Pressure Controllers Market, by Region, 2022-2029 (USD Million)
Table 42 Microfluidic Valves Offered by Key Players
Table 43 Microfluidic Valves Market, by Region, 2022-2029 (USD Million)
Table 44 Micropumps Offered by Key Players
Table 45 Micropumps Market, by Region, 2022-2029 (USD Million)
Table 46 Microneedles Offered by Key Players
Table 47 Microneedles Market, by Region, 2022-2029 (USD Million)
Table 48 Other Microfluidic Components Market, by Region, 2022-2029 (USD Million)
Table 49 Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 50 Silicon-based Microfluidic Components Market, by Region, 2022-2029 (USD Million)
Table 51 Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 52 Polymer-based Microfluidic Components Market, by Region, 2022-2029 (USD Million)
Table 53 Pmma-based Microfluidic Components Market, by Region, 2022-2029 (USD Million)
Table 54 Pdms-based Microfluidic Components Market, by Region, 2022-2029 (USD Million)
Table 55 Coc-based Microfluidic Components Market, by Region, 2022-2029 (USD Million)
Table 56 Other Polymer-based Microfluidic Components Market, by Region, 2022-2029 (USD Million)
Table 57 Glass-based Microfluidic Components Market, by Region, 2022-2029 (USD Million)
Table 58 Microfluidics Market, by Application, 2022-2029 (USD Million)
Table 59 Microfluidics Market for Ivd Applications, by Type, 2022-2029 (USD Million)
Table 60 Microfluidics Market for Ivd Applications, by Region, 2022-2029 (USD Million)
Table 61 Microfluidics Market for Clinical Diagnostics, by Region, 2022-2029 (USD Million)
Table 62 Microfluidics Market for Poct, by Region, 2022-2029 (USD Million)
Table 63 Microfluidics Market for Veterinary Diagnostics, by Region, 2022-2029 (USD Million)
Table 64 Microfluidics Market for Pharmaceutical & Life Science Research, by Type, 2022-2029 (USD Million)
Table 65 Microfluidics Market for Pharmaceutical & Life Science Research, by Region, 2022-2029 (USD Million)
Table 66 Microfluidics Market for Lab Analytics, by Type, 2022-2029 (USD Million)
Table 67 Microfluidics Market for Lab Analytics, by Region, 2022-2029 (USD Million)
Table 68 Microfluidics Market for Proteomic Analysis, by Region, 2022-2029 (USD Million)
Table 69 Microfluidics Market for Genomic Analysis, by Region, 2022-2029 (USD Million)
Table 70 Microfluidics Market for Cell-based Assays, by Region, 2022-2029 (USD Million)
Table 71 Microfluidics Market for Capillary Electrophoresis, by Region, 2022-2029 (USD Million)
Table 72 Microfluidics Market for Microdispensing, by Region, 2022-2029 (USD Million)
Table 73 Microfluidics Market for Microreactors, by Region, 2022-2029 (USD Million)
Table 74 Microfluidics Market for Therapeutics, by Type, 2022-2029 (USD Million)
Table 75 Microfluidics Market for Therapeutics, by Region, 2022-2029 (USD Million)
Table 76 Microfluidics Market for Drug Delivery, by Region, 2022-2029 (USD Million)
Table 77 Microfluidics Market for Wearable Devices, by Region, 2022-2029 (USD Million)
Table 78 Microfluidics Market, by End-user, 2022-2029 (USD Million)
Table 79 Microfluidics Market for Hospitals and Diagnostic Centers, by Region, 2022-2029 (USD Million)
Table 80 Leading Microfluidics Research Institutes, by Area of Interest
Table 81 Microfluidics Market for Academic & Research Institutes, by Region, 2022-2029 (USD Million)
Table 82 Microfluidics Market for Pharmaceutical & Biotechnology Companies, by Region, 2022-2029 (USD Million)
Table 83 Microfluidics Market, by Region, 2022-2029 (USD Million)
Table 84 North America: Macroeconomic Outlook
Table 85 North America: Microfluidics Market, by Country, 2022-2029 (USD Million)
Table 86 North America: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 87 North America: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 88 North America: Microfluidics Market, by Application, 2022-2029 (USD Million)
Table 89 North America: Microfluidics Market for Ivd Applications, by Type, 2022-2029 (USD Million)
Table 90 North America: Microfluidics Market for Pharmaceutical & Life Science Research, by Type, 2022-2029 (USD Million)
Table 91 North America: Microfluidics Market for Lab Analytics, by Type, 2022-2029 (USD Million)
Table 92 North America: Microfluidics Market for Therapeutics, by Type, 2022-2029 (USD Million)
Table 93 North America: Microfluidics Components Market, by Material, 2022-2029 (USD Million)
Table 94 North America: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 95 North America: Microfluidics Market, by End-user, 2022-2029 (USD Million)
Table 96 US: Key Macroindicators
Table 97 US: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 98 US: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 99 US: Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 100 US: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 101 Canada: Key Macroindicators
Table 102 Canada: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 103 Canada: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 104 Canada: Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 105 Canada: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 106 Europe: Macroeconomic Outlook
Table 107 Europe: Microfluidics Market, by Country, 2022-2029 (USD Million)
Table 108 Europe: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 109 Europe: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 110 Europe: Microfluidics Market, by Application, 2022-2029 (USD Million)
Table 111 Europe: Microfluidics Market for Ivd Applications, by Type, 2022-2029 (USD Million)
Table 112 Europe: Microfluidics Market for Pharmaceutical & Life Science Research Applications, by Type, 2022-2029 (USD Million)
Table 113 Europe: Microfluidics Market for Lab Analytics Applications, by Type, 2022-2029 (USD Million)
Table 114 Europe: Microfluidics Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 115 Europe: Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 116 Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 117 Europe: Microfluidics Market, by End-user, 2022-2029 (USD Million)
Table 118 Germany: Key Macroindicators
Table 119 Germany: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 120 Germany: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 121 Germany: Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 122 Germany: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 123 France: Key Macroindicators
Table 124 France: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 125 France: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 126 France: Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 127 France: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 128 UK: Key Macroindicators
Table 129 UK: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 130 UK: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 131 UK: Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 132 UK: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 133 Italy: Key Macroindicators
Table 134 Italy: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 135 Italy: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 136 Italy: Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 137 Italy: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 138 Spain: Key Macroindicators
Table 139 Spain: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 140 Spain: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 141 Spain: Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 142 Spain: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 143 Rest of Europe: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 144 Rest of Europe: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 145 Rest of Europe: Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 146 Rest of Europe: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 147 Asia-Pacific: Macroeconomic Indicators
Table 148 Asia-Pacific: Microfluidics Market, by Country, 2022-2029 (USD Million)
Table 149 Asia-Pacific: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 150 Asia-Pacific: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 151 Asia-Pacific: Microfluidics Market, by Application, 2022-2029 (USD Million)
Table 152 Asia-Pacific: Microfluidics Market for Ivd Applications, by Type, 2022-2029 (USD Million)
Table 153 Asia-Pacific: Microfluidics Market for Pharmaceutical & Life Science Research Applications, by Type, 2022-2029 (USD Million)
Table 154 Asia-Pacific: Microfluidics Market for Lab Analytics Applications, by Type, 2022-2029 (USD Million)
Table 155 Asia-Pacific: Microfluidics Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 156 Asia-Pacific: Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 157 Asia-Pacific: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 158 Asia-Pacific: Microfluidics Market, by End-user, 2022-2029 (USD Million)
Table 159 China: Key Macroindicators
Table 160 China: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 161 China: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 162 China: Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 163 China: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 164 Japan: Key Macroindicators
Table 165 Japan: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 166 Japan: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 167 Japan: Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 168 Japan: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 169 India: Key Macroindicators
Table 170 India: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 171 India: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 172 India: Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 173 India: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 174 Australia: Key Macroindicators
Table 175 Australia: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 176 Australia: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 177 Australia: Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 178 Australia: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 179 South Korea: Key Macroindicators
Table 180 South Korea: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 181 South Korea: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 182 South Korea: Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 183 South Korea: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 184 Rest of Asia-Pacific: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 185 Rest of Asia-Pacific: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 186 Rest of Asia-Pacific: Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 187 Rest of Asia-Pacific: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 188 Latin America: Macroeconomic Outlook
Table 189 Latin America: Microfluidics Market, by Country, 2022-2029 (USD Million)
Table 190 Latin America: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 191 Latin America: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 192 Latin America: Microfluidics Market, by Application, 2022-2029 (USD Million)
Table 193 Latin America: Microfluidics Market for Ivd Applications, by Type, 2022-2029 (USD Million)
Table 194 Latin America: Microfluidics Market for Pharmaceutical & Life Science Research Applications, by Type, 2022-2029 (USD Million)
Table 195 Latin America: Microfluidics Market for Lab Analytics Applications, by Type, 2022-2029 (USD Million)
Table 196 Latin America: Microfluidics Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 197 Latin America: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 198 Latin America: Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 199 Latin America: Microfluidics Market, by End-user, 2022-2029 (USD Million)
Table 200 Brazil: Key Macroindicators
Table 201 Brazil: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 202 Brazil: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 203 Brazil: Microfluidics Component Market, by Material, 2022-2029 (USD Million)
Table 204 Brazil: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 205 Mexico: Key Macroindicators
Table 206 Mexico: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 207 Mexico: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 208 Mexico: Microfluidics Market, Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 209 Mexico: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 210 Rest of Latin America: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 211 Rest of Latin America: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 212 Rest of Latin America: Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 213 Rest of Latin America: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 214 Middle East & Africa: Microfluidics Market, by Region, 2022-2029 (USD Million)
Table 215 Middle East & Africa: Macroeconomic Outlook
Table 216 Middle East & Africa: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 217 Middle East & Africa: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 218 Middle East & Africa: Microfluidics Market, by Application, 2022-2029 (USD Million)
Table 219 Middle East & Africa: Microfluidics Market for Ivd Applications, by Type, 2022-2029 (USD Million)
Table 220 Middle East & Africa: Microfluidics Market for Pharmaceutical & Life Science Research Applications, by Type, 2022-2029 (USD Million)
Table 221 Middle East & Africa: Microfluidics Market for Lab Analytics Applications, by Type, 2022-2029 (USD Million)
Table 222 Middle East & Africa: Microfluidics Market for Therapeutic Applications, by Type, 2022-2029 (USD Million)
Table 223 Middle East & Africa: Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 224 Middle East & Africa: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 225 Middle East & Africa: Microfluidics Market, by End-user, 2022-2029 (USD Million)
Table 226 GCC Countries: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 227 GCC Countries: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 228 GCC Countries: Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 229 GCC Countries: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 230 Rest of Middle East & Africa: Microfluidics Market, by Product, 2022-2029 (USD Million)
Table 231 Rest of Middle East & Africa: Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 232 Rest of Middle East & Africa: Microfluidic Components Market, by Material, 2022-2029 (USD Million)
Table 233 Rest of Middle East & Africa: Polymer-based Microfluidic Components Market, by Type, 2022-2029 (USD Million)
Table 234 Overview of Strategies Deployed by Key Manufacturing Companies
Table 235 Microfluidics Market: Degree of Competition
Table 236 Microfluidics Market: Product Footprint
Table 237 Microfluidics Market: Application Footprint
Table 238 Microfluidics Market: End-user Footprint
Table 239 Microfluidics Market: Region Footprint
Table 240 Microfluidics Market: Detailed List of Key Startup/SME Players
Table 241 Microfluidics Market: Competitive Benchmarking of Key Emerging Players/Startups
Table 242 Microfluidics Market: Product Launches & Approvals, January 2021-August 2024
Table 243 Microfluidics Market: Deals, January 2021-August 2024
Table 244 Microfluidics Market: Expansions, January 2021-August 2024
Table 245 Microfluidics Market: Other Developments, January 2021-August 2024
Table 246 Danaher Corporation: Company Overview
Table 247 Danaher Corporation: Products Offered
Table 248 Danaher Corporation: Deals, January 2021-August 2024
Table 249 Danaher Corporation: Expansions, January 2021-August 2024
Table 250 Illumina, Inc.: Company Overview
Table 251 Illumina Inc.: Products Offered
Table 252 Illumina, Inc.: Product Launches & Approvals, January 2021-August 2024
Table 253 Illumina, Inc.: Deals, January 2021-August 2024
Table 254 bioMérieux: Company Overview
Table 255 bioMérieux: Products Offered
Table 256 bioMérieux: Product Launches & Approvals, January 2021-August 2024
Table 257 Thermo Fisher Scientific Inc.: Company Overview
Table 258 Thermo Fisher Scientific Inc.: Products Offered
Table 259 Thermo Fisher Scientific Inc.: Product Launches & Approvals, January 2021-August 2024
Table 260 Thermo Fisher Scientific Inc.: Deals, January 2021-August 2024
Table 261 Thermo Fisher Scientific Inc.: Expansions, January 2021-August 2024
Table 262 Abbott Laboratories: Company Overview
Table 263 Abbott Laboratories: Products Offered
Table 264 Parker Hannifin Corp: Company Overview
Table 265 Park Hannifin Corp: Products Offered
Table 266 Smc Corporation: Company Overview
Table 267 Smc Corporation: Products Offered
Table 268 Smc Corporation: Product Launches, January 2021-August 2024
Table 269 Idex Corporation: Company Overview
Table 270 Idex Corporation: Products Offered
Table 271 Idex Corporation: Deals, January 2021-August 2024
Table 272 Fortive: Company Overview
Table 273 Fortive: Products Offered
Table 274 Perkinelmer Inc.: Company Overview
Table 275 Perkinelmer Inc.: Products Offered
Table 276 Perkinelmer Inc.: Product Launches, January 2021-August 2024
Table 277 Perkinelmer Inc.: Deals, January 2021-August 2024
Table 278 Agilent Technologies, Inc.: Company Overview
Table 279 Agilent Technologies, Inc.: Products Offered
Table 280 Agilent Technologies, Inc.: Product Launches, January 2021-August 2024
Table 281 Agilent Technologies, Inc.: Deals, January 2021-August 2024
Table 282 Agilent Technologies, Inc.: Expansions, January 2021-August 2024
Table 283 Bio-Rad Laboratories, Inc.: Company Overview
Table 284 Bio-Rad Laboratories, Inc.: Products Offered
Table 285 Bio-Rad Laboratories, Inc.: Product Launches, January 2021-August 2024
Table 286 Bio-Rad Laboratories, Inc.: Deals, January 2021-August 2024
Table 287 Becton, Dickinson and Company: Company Overview
Table 288 Becton, Dickinson and Company: Products Offered
Table 289 Becton, Dickinson and Company: Product Launches & Approvals, January 2021-August 2024
Table 290 Becton, Dickinson and Company: Deals, January 2021-August 2024
Table 291 Becton, Dickinson and Company: Expansions, January 2021-August 2024
Table 292 F. Hoffmann-La Roche Ltd.: Company Overview
Table 293 F. Hoffmann-La Roche Ltd.: Products Offered
Table 294 F. Hoffmann-La Roche Ltd.: Product Launches & Approvals, January 2021-August 2024
Table 295 F. Hoffmann-La Roche Ltd.: Deals, January 2021-August 2024
Table 296 Standard Biotools: Company Overview
Table 297 Standard Biotools: Products Offered
Table 298 Standard Biotools: Product Launches & Approvals, January 2021-August 2024
Table 299 Standard Biotools: Deals, January 2021-August 2024
Table 300 Quidelortho Corporation: Company Overview
Table 301 Quidelortho Corporation: Products Offered
Table 302 Quidelortho Corporation: Product Approvals, January 2021-August 2024
Table 303 Quidelortho Corporation: Deals, January 2021-August 2024
Table 304 Quidelortho Corporation: Expansions, January 2021-August 2024
Table 305 Hologic, Inc.: Company Overview
Table 306 Hologic, Inc.: Products Offered
Table 307 Hologic, Inc.: Product Approvals, January 2021-August 2024
Table 308 Hologic, Inc.: Deals, January 2021-August 2024
Table 309 Aignep S.P.A.: Company Overview
Table 310 Aignep S.P.A.: Products Offered
Table 311 Aignep S.P.A.: Deals, January 2021-August 2024
Table 312 Dolomite Microfluidics: Company Overview
Table 313 Dolomite Microfluidics: Products Offered
Table 314 Dolomite Microfluidics: Product Launches & Approvals, January 2021-August 2024
Table 315 Dolomite Microfluidics: Deals, January 2021-August 2024
Table 316 Dolomite Microfluidics: Other Developments, January 2021-August 2024
Table 317 Elveflow: Company Overview
Table 318 Elveflow: Products Offered
Table 319 Nanostring Technologies: Company Overview
Table 320 Nortis Inc.: Company Overview
Table 321 Innovative Biochips, LLC: Company Overview
Table 322 Fluidic Analytics: Company Overview
Table 323 Ufluidix: Company Overview
Table 324 Horiba: Company Overview
Table 325 Micronit B.V.: Company Overview
List of Figures
Figure 1 Microfluidics Market Segmentation
Figure 2 Microfluidics Market: Research Design
Figure 3 Primary Sources
Figure 4 Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 5 Breakdown of Primary Interviews: Supply-Side and Demand-Side Participants
Figure 6 Research Methodology: Hypothesis Building
Figure 7 Microfluidics Market Size Estimation: Approach 1 (Company Revenue Estimation)
Figure 8 Microfluidics Market Size Estimation: Bottom-Up Approach
Figure 9 CAGR Projections: Supply-Side Analysis
Figure 10 Top-Down Approach
Figure 11 Data Triangulation
Figure 12 Microfluidics Market, by Product, 2024 vs. 2029 (USD Million)
Figure 13 Microfluidic Components Market, by Type, 2024 vs. 2029 (USD Million)
Figure 14 Microfluidics Market, by Application, 2024 vs. 2029 (USD Million)
Figure 15 Microfluidics Market, by End-user, 2024 vs. 2029 (USD Million)
Figure 16 Geographical Snapshot of Microfluidics Market, 2024-2029
Figure 17 Growing Demand for Point-Of-Care Testing to Drive Market
Figure 18 Hospitals and Diagnostic Centers Segment Accounted for Largest Market Share for Japan in 2023
Figure 19 North America to Dominate Microfluidics Market in 2024
Figure 20 China to Account for Highest Growth Rate During Forecast Period
Figure 21 Microfluidics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 22 Global Cancer Incidence, 2020-2040
Figure 23 Microfluidics Market: Porter's Five Forces Analysis
Figure 24 Influence of Stakeholders on Buying Process for Microfluidics Market, by Material
Figure 25 Key Buying Criteria, by Material
Figure 26 US: Regulatory Process for Testing Devices Associated with Microfluidics Technology
Figure 27 Canada: Regulatory Process for Microfluidics-Associated Ivd Devices in Canada
Figure 28 Europe: Regulatory Process for Ivd Devices
Figure 29 India: Regulatory Process for Ivd Devices
Figure 30 Microfluidics Market: Ecosystem Analysis
Figure 31 Microfluidics Market: Value Chain Analysis
Figure 32 Microfluidics Market: Supply Chain Analysis
Figure 33 Revenue Shift and New Revenue Pockets
Figure 34 Top Applicants and Owners (Companies/Institutions) for Microfluidics Patents (January 2014-August 2024)
Figure 35 Average Selling Price Trend of Products, by Region, 2021- 2023 (USD)
Figure 36 Average Selling Price of Top 3 Applications, by Key Player
Figure 37 Investment & Funding Scenario, 2019-2023
Figure 38 Number of Investor Deals, by Key Players, 2019-2023
Figure 39 Value of Investor Deals by Key Players, 2019-2023 (USD Million)
Figure 40 North America: Microfluidics Market Snapshot
Figure 41 Asia-Pacific: Microfluidics Market Snapshot
Figure 42 Revenue Analysis of Key Players in Microfluidics Market (2019-2023)
Figure 43 Market Share Analysis of Key Players in Microfluidics Market (2023)
Figure 44 Ranking of Key Players in Microfluidics Market, 2023
Figure 45 Microfluidics Market: Company Evaluation Matrix (Key Players), 2023
Figure 46 Microfluidics Market: Company Footprint
Figure 47 Microfluidics Market: Company Evaluation Matrix (Startups/SMEs), 2023
Figure 48 EV/EBITDA of Key Vendors
Figure 49 Year-To-Date (YTD) Price Total Return and 5-Year Stock Beta of Key Vendors
Figure 50 Microfluidics Market: Brand/Product Comparative Analysis
Figure 51 Danaher Corporation: Company Snapshot (2023)
Figure 52 Illumina, Inc.: Company Snapshot (2023)
Figure 53 bioMérieux: Company Snapshot (2023)
Figure 54 Thermo Fisher Scientific Inc.: Company Snapshot (2023)
Figure 55 Abbott Laboratories: Company Snapshot (2023)
Figure 56 Parker Hannifin Corp: Company Snapshot (2023)
Figure 57 Smc Corporation: Company Snapshot (2023)
Figure 58 Idex Corporation: Company Snapshot (2023)
Figure 59 Fortive: Company Snapshot (2023)
Figure 60 Perkinelmer Inc.: Company Snapshot (2023)
Figure 61 Agilent Technologies, Inc.: Company Snapshot (2023)
Figure 62 Bio-Rad Laboratories, Inc.: Company Snapshot (2023)
Figure 63 Becton, Dickinson and Company: Company Snapshot (2023)
Figure 64 F. Hoffmann-La Roche Ltd.: Company Snapshot (2023)
Figure 65 Standard Biotools: Company Snapshot (2023)
Figure 66 Quidelortho Corporation: Company Snapshot (2023)
Figure 67 Hologic, Inc.: Company Snapshot (2023)

Companies Mentioned

  • Danaher Corporation
  • Illumina, Inc.
  • Biomérieux
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Parker Hannifin Corp
  • Smc Corporation
  • Idex Corporation
  • Fortive
  • Perkinelmer Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd.
  • Standard Biotools
  • Quidelortho Corporation
  • Hologic, Inc.
  • Aignep S.P.A.
  • Dolomite Microfluidics
  • Elveflow
  • Nanostring Technologies
  • Nortis Inc.
  • Innovative Biochips, LLC
  • Fluidic Analytics
  • Ufluidix
  • Horiba
  • Micronit B.V.

Methodology

Loading
LOADING...

Table Information